Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility

Singapore

THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.

The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.

New York-listed Thermo Fisher plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufa…

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL